Cetera Investment Advisers purchased a new position in shares of Kindly MD, Inc. (NASDAQ:KDLY – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 75,369 shares of the company’s stock, valued at approximately $93,000. Cetera Investment Advisers owned approximately 1.26% of Kindly MD at the end of the most recent quarter.
Kindly MD Trading Up 0.8%
NASDAQ KDLY opened at $22.60 on Tuesday. The firm’s fifty day moving average price is $7.31 and its two-hundred day moving average price is $3.55. Kindly MD, Inc. has a 1 year low of $0.65 and a 1 year high of $34.77. The firm has a market capitalization of $136.10 million and a P/E ratio of -29.35.
Kindly MD (NASDAQ:KDLY – Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported ($0.17) earnings per share (EPS) for the quarter.
Kindly MD Profile
Kindly MD, Inc provides healthcare services. Its services include medication management, behavioral healthcare and alternative treatments. The firm offers evaluation and management, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.
Recommended Stories
- Five stocks we like better than Kindly MD
- How to Invest in Blue Chip Stocks
- Ulta’s Beautiful Q1 Earnings Report Points to More Gains Ahead
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Top 3 ETFs Defense Hawks Are Buying
- 3 Fintech Stocks With Good 2021 Prospects
- Zscaler Will Hit $360 Soon: Here’s the How and Why
Want to see what other hedge funds are holding KDLY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kindly MD, Inc. (NASDAQ:KDLY – Free Report).
Receive News & Ratings for Kindly MD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindly MD and related companies with MarketBeat.com's FREE daily email newsletter.